GT Medical Technologies Announces FDA Clearance of Expanded Indication for GammaTile Therapy
Earlier today, GT Medical Technologies of Tempe, Arizona announced patients with newly diagnosed malignant tumors are now eligible to receive FDA-cleared GammaTile® Therapy in addition to patients with recurrent brain tumors.
January 28, 2020